financetom
Business
financetom
/
Business
/
Denali Capital Acquisition Pushes Merger Deadline With Extra Funding
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Denali Capital Acquisition Pushes Merger Deadline With Extra Funding
Mar 12, 2025 1:52 AM

04:33 AM EDT, 03/12/2025 (MT Newswires) -- Denali Capital Acquisition ( DECA ) said Tuesday it has moved its business combination deadline to April 11 and has placed $15,063 into its trust fund.

The extension was backed by a zero-interest note from Scilex Holding ( SCLX ) , which allows Denali to borrow $180,000, repayable upon either a completed deal or liquidation, and convertible into class A shares at $10 per share, the company said.

Denali said the remaining balance of $59,545 under the note can be used to fund another monthly extensions if needed.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Citigroup cuts more jobs to meet expense goals, Bloomberg News reports
Citigroup cuts more jobs to meet expense goals, Bloomberg News reports
Jan 16, 2025
(Reuters) -Citigroup ( C/PN ) is cutting more jobs this week to meet CEO Jane Fraser's expense goals, Bloomberg News reported on Thursday, citing people familiar with the matter.  Managing directors in the wealth and technology units are leaving the firm and Citi is also axing people from a team that compiles data and analysis on the bank's clients, according...
New Analysis of Omeros' Narsoplimab to Treat Complications From Stem Cell Transplant Support Results
New Analysis of Omeros' Narsoplimab to Treat Complications From Stem Cell Transplant Support Results
Jan 16, 2025
02:17 PM EST, 01/16/2025 (MT Newswires) -- Omeros ( OMER ) said Thursday that results from a statistical analysis of narsoplimab, its monoclonal antibody to treat hematopoietic stem cell transplant-associated thrombotic microangiopathy, or TA-TMA, showed robustness of the previously reported primary endpoint analysis. The company said that newly completed sensitivity analyses confirm the survival benefit of narsoplimab in patients with...
Why Katapult Holdings (KPLT) Shares Are Up 63% Today
Why Katapult Holdings (KPLT) Shares Are Up 63% Today
Jan 16, 2025
Katapult Holdings Inc ( KPLT ) shares are trading higher by 63% to $11.41 during Thursday’s session after the company reported $75.2 million in gross originations for the fourth quarter of 2024, up 11.3% year-over-year and surpassing its November forecast of 6-8% growth. What To Know: Katapult ( KPLT ) says this marks the ninth consecutive quarter of annual growth...
Issuer Direct to Be Renamed ACCESS Newswire, Change Ticker to ACCS
Issuer Direct to Be Renamed ACCESS Newswire, Change Ticker to ACCS
Jan 16, 2025
02:18 PM EST, 01/16/2025 (MT Newswires) -- Issuer Direct ( ISDR ) said Thursday it will change its name to ACCESS Newswire and trade under the new ticker ACCS on the NYSE American Exchange, effective Jan. 27. No action is required by stockholders with respect to the changes, the company said. Price: 9.00, Change: +0.14, Percent Change: +1.58 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved